The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors and therapeutic options for epithelioid hemangioendothelioma (EHE): A multicenter analysis of a series of fifty-seven cases.
 
Aurore Vozy
No Relationships to Disclose
 
Audrey Simonaggio
No Relationships to Disclose
 
Philippe Terrier
No Relationships to Disclose
 
Valerie Paradis
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Olivier Mir
Stock and Other Ownership Interests - Transgene
Honoraria - Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; SERVIER; Vifor Pharma
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Pfizer; PharmaMar; Roche
 
Charles Honoré
No Relationships to Disclose
 
Sarah Naomie Dumont
Honoraria - Amgen; Vifor Pharma
Travel, Accommodations, Expenses - Abbvie; Lilly; Pfizer; Sandoz
 
Jean-Philippe Spano
Honoraria - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Leo Pharma; Lilly; MSD; Myriad Genetics; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - MSD; Roche
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; MSD; Myriad Genetics; Pfizer; Pierre Fabre; Roche
 
Axel Le Cesne
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar